Insider Stock Trading History of Eastbourne Capital Management Llc/ca


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Eastbourne Capital Management Llc/ca since year 2005. The trader's CIK number is 1140888. At the time of this reporting, Eastbourne Capital Management Llc/ca is the 10% Owner of Avi Biopharma Inc . (stock ticker symbol AVII). See this page for all insider trading activities at Avi Biopharma Inc .

Note that in the past EASTBOURNE CAPITAL MANAGEMENT LLC/CA also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Eastbourne Capital Management Llc/ca since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2010-03-04 AVII Avi Biopharma Inc Sale 4,094,646 1.24 5,077,361
2009-11-11 AVII Avi Biopharma Inc Sale 333,950 1.42 475,878
2009-09-28 TELK Telik Inc Sale 213,547 .86 184,077
2009-09-29 TELK Telik Inc Sale 143,068 .81 116,457
2009-09-30 TELK Telik Inc Sale 47,385 .80 38,002
2009-09-28 PTIE Pain Therapeutics Inc Sale 1,556,842 4.99 7,763,971
2009-09-25 PTIE Pain Therapeutics Inc Sale 1,518,000 4.98 7,552,049
2009-09-29 PTIE Pain Therapeutics Inc Sale 2,073 4.98 10,317
2009-09-22 TELK Telik Inc Sale 948,538 .92 877,397
2009-09-21 TELK Telik Inc Sale 126,653 .99 125,133
2009-09-16 AMLN Amylin Pharmaceuticals Inc Sale 2,410,639 14.16 34,137,058
2009-09-17 AMLN Amylin Pharmaceuticals Inc Sale 1,443,241 13.96 20,150,530
2009-09-16 TELK Telik Inc Sale 104,709 1.20 125,127
2009-09-17 TELK Telik Inc Sale 41,100 1.19 48,950
2009-09-14 MTG Mgic Investment Corp Sale 1,500,000 9.16 13,735,500
2009-09-15 MTG Mgic Investment Corp Sale 2,100,000 9.10 19,099,500
2009-09-16 MTG Mgic Investment Corp Sale 4,600,245 8.98 41,296,399
2009-08-07 PTIE Pain Therapeutics Inc Sale 1,663,000 3.96 6,585,480
2009-07-13 PTIE Pain Therapeutics Inc Sale 45,778 4.19 191,626
2009-07-14 PTIE Pain Therapeutics Inc Sale 45,000 4.27 192,060
2009-07-07 PTIE Pain Therapeutics Inc Sale 368,000 4.58 1,686,176
2009-06-12 PTIE Pain Therapeutics Inc Sale 185,780 5.17 961,225
2009-06-11 PTIE Pain Therapeutics Inc Sale 71,820 5.01 359,961
2009-06-15 PTIE Pain Therapeutics Inc Sale 28,103 5.06 142,313
2009-06-08 PTIE Pain Therapeutics Inc Sale 286,467 5.34 1,530,306
2009-06-09 PTIE Pain Therapeutics Inc Sale 98,969 5.28 522,160
2009-06-10 PTIE Pain Therapeutics Inc Sale 75,838 5.12 388,214
2009-04-06 PTIE Pain Therapeutics Inc Sale 215,803 3.98 858,248
2009-04-03 PTIE Pain Therapeutics Inc Sale 83,663 4.10 342,850
2009-04-02 PTIE Pain Therapeutics Inc Sale 600,534 4.22 2,534,854
2009-03-11 MTG Mgic Investment Corp Buy 73,099 .99 72,368
2009-03-12 MTG Mgic Investment Corp Buy 2,988,158 .86 2,578,780
2009-03-02 PTIE Pain Therapeutics Inc Sale 1,000,000 3.70 3,697,000
2009-02-13 TELK Telik Inc Buy 27,422 .46 12,477
2009-02-12 TELK Telik Inc Buy 126,202 .44 56,033
2009-02-11 TELK Telik Inc Buy 22,482 .46 10,229
2009-02-10 TELK Telik Inc Buy 43,440 .46 19,765
2009-01-30 TELK Telik Inc Buy 13,617 .46 6,195
2009-02-02 TELK Telik Inc Buy 31,160 .46 14,177
2009-01-27 TELK Telik Inc Buy 62,649 .47 29,319
2009-01-28 TELK Telik Inc Buy 511 .48 242
2009-01-29 TELK Telik Inc Buy 7,500 .47 3,510
2009-01-22 TELK Telik Inc Buy 322,809 .49 157,207
2009-01-20 TELK Telik Inc Buy 29,566 .45 13,422
2009-01-13 TELK Telik Inc Buy 40,273 .40 15,907
2009-01-15 TELK Telik Inc Buy 87,485 .46 39,980
2008-12-31 TELK Telik Inc Buy 485,690 .36 176,305
2009-01-05 TELK Telik Inc Buy 26,343 .38 10,036
2009-01-02 TELK Telik Inc Buy 111,466 .37 41,130
2008-12-29 TELK Telik Inc Buy 146,571 .32 46,756
2008-12-30 TELK Telik Inc Buy 414,814 .35 144,770
2008-08-27 AMLN Amylin Pharmaceuticals Inc Sale 6,026,562 21.00 126,533,695
2008-06-23 TELK Telik Inc Sale 4,261,019 1.26 5,368,883
2008-06-06 AMLN Amylin Pharmaceuticals Inc Buy 150,000 29.92 4,488,000
2008-05-07 AMLN Amylin Pharmaceuticals Inc Buy 250,000 27.90 6,975,000
2008-04-30 AMLN Amylin Pharmaceuticals Inc Buy 356,652 27.72 9,886,393
2008-04-21 AMLN Amylin Pharmaceuticals Inc Buy 894,000 29.04 25,957,290
2008-04-16 AMLN Amylin Pharmaceuticals Inc Buy 19,471 30.78 599,317
2008-04-17 AMLN Amylin Pharmaceuticals Inc Buy 50,000 30.35 1,517,500
2008-04-14 AMLN Amylin Pharmaceuticals Inc Buy 147,308 29.42 4,333,212
2008-04-15 AMLN Amylin Pharmaceuticals Inc Buy 28,689 29.27 839,727
2008-04-11 AMLN Amylin Pharmaceuticals Inc Buy 291,300 29.98 8,733,756
2008-04-09 AMLN Amylin Pharmaceuticals Inc Buy 208,700 30.05 6,271,435
2008-04-08 AMLN Amylin Pharmaceuticals Inc Buy 50,000 30.96 1,548,000
2008-04-07 AMLN Amylin Pharmaceuticals Inc Buy 50,000 31.52 1,576,000
2008-04-03 AMLN Amylin Pharmaceuticals Inc Buy 155,000 30.56 4,736,025
2008-03-28 AMLN Amylin Pharmaceuticals Inc Buy 118,933 28.10 3,342,017
2008-03-26 AMLN Amylin Pharmaceuticals Inc Buy 41,067 28.06 1,152,134
2008-03-25 AMLN Amylin Pharmaceuticals Inc Buy 90,000 28.61 2,574,900
2008-03-17 AMLN Amylin Pharmaceuticals Inc Buy 30,316 24.50 742,742
2008-03-17 AMLN Amylin Pharmaceuticals Inc Buy 30,316 24.50 742,742
2008-02-29 AMLN Amylin Pharmaceuticals Inc Buy 50,000 26.59 1,329,300
2008-02-28 AMLN Amylin Pharmaceuticals Inc Buy 25,000 27.40 685,000
2008-01-14 PTIE Pain Therapeutics Inc Buy 11,450 9.75 111,637
2008-01-15 PTIE Pain Therapeutics Inc Buy 8,550 9.63 82,336
2008-01-16 PTIE Pain Therapeutics Inc Buy 275 9.53 2,620
2008-01-17 PTIE Pain Therapeutics Inc Buy 29,700 9.50 282,298
2008-01-22 PTIE Pain Therapeutics Inc Buy 17,325 8.89 154,019
2008-02-28 PTIE Pain Therapeutics Inc Buy 25,000 8.89 222,250
2008-01-29 PTIE Pain Therapeutics Inc Buy 20,344 9.03 183,706
2008-01-30 PTIE Pain Therapeutics Inc Buy 37,056 8.95 331,651
2008-02-22 PTIE Pain Therapeutics Inc Buy 10,000 8.98 89,800
2008-02-29 PTIE Pain Therapeutics Inc Buy 15,000 8.76 131,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Eastbourne Capital Management Llc/ca (10% Owner of Avi Biopharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.